<DOC>
	<DOCNO>NCT01782170</DOCNO>
	<brief_summary>The purpose study explore efficacy Iocide oral rinse human clinical trial gingivitis . Iocide oral rinse evaluate placebo rinse . Indices gingivitis , plaque bleeding score blood test perform determine effect antimicrobial oral rinse relative level biological marker inflammation .</brief_summary>
	<brief_title>Efficacy Iocide Oral Rinse Against Gingival Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Gingivitis</mesh_term>
	<criteria>Subjects shall meet follow inclusion criterion eligible participation study : Males nonpregnant female least 18 year age , good general health , determine Investigator ; Have least 16 natural , gradable teeth good dental health , determine Investigator ; Have &gt; 25 % site Gingival Index ( GI ) score &gt; 2 Visits 1 2 ; Have Plaque Index ( PI ) score &gt; 1 &gt; 50 % site ; Use effective method contraception duration study permanently sterilize ; Able willing comply study requirement include follow instruction study treatment return followup visit require protocol ; Have full understanding element , signature date write informed consent prior initiation protocol specify procedure ; Females childbearing potential must negative pregnancy test study period . Sexually active female must use effective form birth control abstinence . These method include oral contraceptive ( `` pill '' ) , intrauterine device ( IUD ) , levonogestrol implant ( Norplant® ) , medroxyprogesterone acetate injection ( Depoprovera® ) contraceptive foam condom . Subjects meet follow exclusion criterion eligible participation study : History , current evidence , significant acute chronic subjectreported medical psychiatric condition , opinion Investigator , would render examination difficult invalid prevent subject active study participation ; ≤24 % sit GI score &gt; 2 ; Thyroid peroxidase antibody ( TPOab ) positive &gt; 34 ; Screening serum level thyroid stimulate hormone ( TSH ) &lt; 0.45 &gt; 4.5 ; Treatment antibiotic within one ( 1 ) month period prior screen examination ; History heart murmur , history rheumatic fever , valvular disease , prosthetic implant condition require antibiotic premedication ; History thyroid disease ; Purported sensitivity allergy iodine ; Known sensitivity allergy shellfish ; History diabetes ; History autoimmune disease ; Gross oral pathology ( periodontal disease , rampant caries , tissue damage create poor oral care treatment , soft hard tissue tumor ) , opinion Investigator , could influence outcome study ; True periodontal pocket &gt; 5 mm and/or visible recession indicative attachment loss ; Current sign symptom mucosal tissue ulceration inflammation , canker sore ; Presence orthodontic appliance removable appliance impinges oral tissue assess ; History early onset periodontal disease acute necrotizing ulcerative gingivitis ; Subject report history past 6 month current alcohol abuse , opinion Investigator , could influence outcome study ; Subject report history last past 6 month current drug abuse ; Chronic treatment ( 2 week ) medication know affect periodontal status ( include phenytoin , calcium antagonist , cyclosporine , coumarin , nonsteroidal antiinflammatory drug , aspirin ) within 1 month screen examination . All medication chronic medical condition initiate least 3 month enrollment ; Current use statin use statin within past sixty ( 60 ) day screen ; Concomitant therapy another investigational drug device without prior approval Sponsor within four week prior Visit 2 ( Study Day 1 ) ; Concomitant endodontic periodontal therapy prophylaxis past six ( 6 ) month ; Females childbearing potential positive pregnancy test , pregnant nursing mother , suspected pregnancy , intention become pregnant study ; Residence household subject already enrol study ( inclusion may create blind and/or compliance issue ) ; Unable unwilling comply informed consent process , meet study requirement include follow instruction study intervention , return followup visit require protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Gingivitis</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Biological Markers Inflammation</keyword>
</DOC>